Works matching AU Cho, S-G

Results: 29

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 8, p. 1132, doi. 10.1038/bmt.2015.110

By:

Kim, M;
Yahng, S-A;
Kwon, A;
Park, J;
Jeon, Y-W;
Yoon, J-H;
Shin, S-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Lee, S;
Min, C-K;
Kim, H-J;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Lee, S-H;
Kim, Y-J

Publication type:

Article

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Published in:

Bone Marrow Transplantation, 2015, v. 50, n. 3, p. 354, doi. 10.1038/bmt.2014.281

By:

Kim, M;
Park, J;
Kim, D-W;
Kim, Y-J;
Jeon, Y-W;
Yoon, J-H;
Shin, S-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, H-J;
Min, C-Ki;
Cho, S-G;
Kim, Y;
Lee, J-W;
Han, K;
Min, W-S;
Lee, S

Publication type:

Article

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 12, p. 1466, doi. 10.1038/bmt.2014.180

By:

Yoon, J-H;
Kim, H-J;
Kim, J-W;
Jeon, Y-W;
Shin, S-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, Y-J;
Lee, S;
Min, C-K;
Cho, S-G;
Lee, J-W;
Min, W-S;
Park, C-W

Publication type:

Article

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL.

Published in:

Bone Marrow Transplantation, 2014, v. 49, n. 6, p. 773, doi. 10.1038/bmt.2014.54

By:

Shin, S-H;
Yoon, J-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W;
Lee, S

Publication type:

Article

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 12, p. 1562, doi. 10.1038/bmt.2013.101

By:

Yoon, J-H;
Min, W-S;
Kim, H-Je;
Kim, J-H;
Shin, S-H;
Yahng, S-A;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Kim, Y-J;
Lee, S;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Park, C-W

Publication type:

Article

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 5, p. 678, doi. 10.1038/bmt.2012.214

By:

Shin, S-H;
Yahng, S-A;
Yoon, J-H;
Lee, S-E;
Cho, B-S;
Eom, K-S;
Lee, S;
Min, C-K;
Kim, H-J;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W;
Kim, Y-J

Publication type:

Article

Risk and prognostic factors for acute GVHD based on NIH consensus criteria.

Published in:

Bone Marrow Transplantation, 2013, v. 48, n. 4, p. 587, doi. 10.1038/bmt.2012.187

By:

Lee, S-E;
Cho, B-S;
Kim, J-H;
Yoon, J-H;
Shin, S-H;
Yahng, S-A;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Lee, S;
Min, C-K;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Park, C-W

Publication type:

Article

Successful treatment with tandem consolidation using 90yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis.

Published in:

Bone Marrow Transplantation, 2012, v. 47, n. 6, p. 877, doi. 10.1038/bmt.2011.193

By:

Han, E J;
Yang, S-A;
Sohn, H-S;
Kim, J I;
Kang, C-S;
Cho, S-G

Publication type:

Article

HLA-matched sibling transplantation with BM and CD34+-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.

Published in:

Bone Marrow Transplantation, 2010, v. 45, n. 10, p. 1497, doi. 10.1038/bmt.2009.374

By:

Cho, B. S.;
Eom, K. S.;
Kim, Y. J.;
Kim, H. J.;
Lee, S.;
Min, C. K.;
Cho, S. G.;
Min, W. S.;
Park, C. W.;
Kim, C. C.;
Lee, J. W.

Publication type:

Article

Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center.

Published in:

2010

By:

Kim, S.-Y.;
Cho, S.-G.;
Cho, B.-S.;
Kim, M.-S.;
Eom, K.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Lee, S.;
Min, C.-K.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.

Publication type:

Letter

Potential role of adoptively transferred allogeneic WT1-specific CD4+ and CD8+ T lymphocytes for the sustained remission of refractory AML.

Published in:

2010

By:

Kim, Y.-J.;
Cho, S.-G.;
Lee, S.;
Kim, M.-S.;
Kim, E.-K.;
Cho, B.-S.;
Sohn, H.-J.;
Choi, H. B.;
Eom, K.-S.;
Min, C.-K.;
Kim, H.-J.;
Kim, Y.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Kim, C.-C.;
Kim, T.-G.

Publication type:

Case Study

Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML.

Published in:

Bone Marrow Transplantation, 2009, v. 44, n. 6, p. 345, doi. 10.1038/bmt.2009.42

By:

Kim, H.-J.;
Min, W.-S.;
Cho, B.-S.;
Eom, K.-S.;
Kim, S.-Y.;
Kim, Y.-J.;
Lee, S.;
Min, C.-K.;
Cho, S.-G.;
Lee, J.-W.;
Kim, C.-C.

Publication type:

Article

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2008, v. 41, n. 9, p. 813, doi. 10.1038/sj.bmt.1705976

By:

Cho, B.-S.;
Min, C.-K.;
Eom, K.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Lee, S.;
Cho, S.-G.;
Kim, Y.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Kim, C.-C.

Publication type:

Article

Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.

Published in:

Bone Marrow Transplantation, 2007, v. 40, n. 11, p. 1069, doi. 10.1038/sj.bmt.1705873

By:

Kim, H.-J.;
Min, W.-S.;
Eom, K.-S.;
Cho, B.-S.;
Kim, S.-Y.;
Bok, J.-N.;
Kim, K.-S.;
Min, C.-K.;
Lee, S.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Kim, C.-C.

Publication type:

Article

Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2006, v. 38, n. 2, p. 149, doi. 10.1038/sj.bmt.1705410

By:

Min, C.-K.;
Kim, S. Y.;
Lee, M. J.;
Eom, K. S.;
Kim, Y. J.;
Kim, H. J.;
Lee, S.;
Cho, S. G.;
Kim, D. W.;
Lee, J. W.;
Min, W. S.;
Kim, C. C.;
Cho, C. S.

Publication type:

Article

Transient Plasma Measured by Fixed Electric Probes in the Scrape-Off Layer of Korean Superconducting Tokamak Advance Research (KSTAR).

Published in:

Contributions to Plasma Physics, 2013, v. 53, n. 1, p. 75, doi. 10.1002/ctpp.201310013

By:

Oh, Y.-S.;
Bak, J.-G.;
Woo, H.-J.;
Park, E.-K.;
Kim, H.-S.;
Cho, S.-G.;
Park, S.-J.;
Lho, T.;
Chung, K.-S.

Publication type:

Article

Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation.

Published in:

Bone Marrow Transplantation, 2001, v. 28, n. 10, p. 987, doi. 10.1038/sj.bmt.1703259

By:

Cho, S G;
Lim, J;
Kim, Y;
Eom, H S;
Jin, C Y;
Han, C W;
Kim, C C

Publication type:

Article

Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.

Published in:

Bone Marrow Transplantation, 1997, v. 19, n. 2, p. 187, doi. 10.1038/sj.bmt.1700631

By:

Choi, J H;
Kim, D W;
Cho, S G;
Yoo, J H;
Jeong, D C;
Han, C W;
Shin, W S;
Min, W S;
Kim, H K;
Kim, C C;
Kim, D J

Publication type:

Article

Gallbladder carcinoma and chronic cholescystitis: differentiation with two-phase spiral CT.

Published in:

Abdominal Imaging, 2004, v. 29, n. 1, p. 102, doi. 10.1007/s00261-003-0080-4

By:

Yun, E. J.;
Cho, S. G.;
Park, S.;
Park, S.-W.;
Kim, W.-H.;
Kim, H.-J.;
Suh, C. H.

Publication type:

Article

Cementless total ankle arthroplasty in diabetic neuropathic arthropathy.

Published in:

Diabetic Medicine, 2008, v. 25, n. 11, p. 1358, doi. 10.1111/j.1464-5491.2008.02576.x

By:

Lee, K.-B.;
Cho, S.-G.;
Seon, J.-K.

Publication type:

Article

Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.

Published in:

Cell Death & Differentiation, 2012, v. 19, n. 5, p. 859, doi. 10.1038/cdd.2011.168

By:

Cho, J-H;
Lee, M-K;
Yoon, K W;
Lee, J;
Cho, S-G;
Choi, E-J

Publication type:

Article

Effect of Follicle Stimulation Hormone and Luteinizing Hormone on Cumulus Cell Expansion and In Vitro Nuclear Maturation of Canine Oocytes.

Published in:

Reproduction in Domestic Animals, 2007, v. 42, n. 6, p. 561, doi. 10.1111/j.1439-0531.2006.00818.x

By:

Lee, H.-S.;
Seo, Y.-I.;
Yin, X.-J.;
Cho, S.-G.;
Lee, S.-S.;
Kim, N.-H.;
Cho, S.-K.;
Kong, I.-K.

Publication type:

Article

The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

Published in:

2011

By:

Jeon, E. K.;
Lim, J.;
Kim, M.;
Yahng, S.-A.;
Lee, S.-E.;
Cho, B.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Park, C.-W.;
Lee, S.

Publication type:

Letter

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2010, v. 24, n. 12, p. 2110, doi. 10.1038/leu.2010.217

By:

Lee, S.;
Chung, N.-G.;
Cho, B.-S.;
Eom, K.-S.;
Kim, Y.-J.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Park, C.-W.;
Kim, C.-C.

Publication type:

Article

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.

Published in:

Leukemia (08876924), 2009, v. 23, n. 10, p. 1763, doi. 10.1038/leu.2009.102

By:

Cho, B.-S.;
Lee, S.;
Kim, Y.-J.;
Chung, N.-G.;
Eom, K.-S.;
Kim, H.-J.;
Min, C.-K.;
Cho, S.-G.;
Kim, D.-W.;
Lee, J.-W.;
Min, W.-S.;
Kim, C.-C.

Publication type:

Article

Feasibility of NIH consensus criteria for chronic graft-versus-host disease.

Published in:

Leukemia (08876924), 2009, v. 23, n. 1, p. 78, doi. 10.1038/leu.2008.276

By:

Cho, B-S;
Min, C-K;
Eom, K-S;
Kim, Y-J;
Kim, H-J;
Lee, S;
Cho, S-G;
Kim, D-W;
Lee, J-W;
Min, W-S;
Kim, C-C

Publication type:

Article

Tuberculosis before hematopoietic stem cell transplantation in patients with hematologic diseases: report of a single-center experience.

Published in:

Transplant Infectious Disease, 2015, v. 17, n. 1, p. 73, doi. 10.1111/tid.12341

By:

Eom, K.‐S.;
Lee, D.‐G.;
Lee, H.‐J.;
Cho, S.‐Y.;
Choi, S.‐M.;
Choi, J.‐K.;
Kim, Y.‐J.;
Lee, S.;
Kim, H.‐J.;
Cho, S.‐G.;
Lee, J.‐W.

Publication type:

Article

Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin.

Published in:

Transplant Infectious Disease, 2009, v. 11, n. 5, p. 413, doi. 10.1111/j.1399-3062.2009.00414.x

By:

Park, S. H.;
Choi, S.-M.;
Lee, D.-G.;
Choi, J.-H.;
Yoo, J.-H.;
Kim, S.-H.;
Kim, H.-J.;
Cho, S.-G.;
Eom, K.-S.;
Lee, J.-W.;
Min, W.-S.;
Shin, W.-S.;
Kim, C.-C.

Publication type:

Article

Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.

Published in:

International Journal of Laboratory Hematology, 2008, v. 30, n. 6, p. 508, doi. 10.1111/j.1751-553X.2007.00991.x

By:

KIM, M.;
LEE, S.;
JUNG, C. K.;
LIM, J.;
CHO, S. G.;
KIM, D. W.;
KIM, Y.;
HAN, K.;
MIN, W. S.;
KIM, C. C.

Publication type:

Article

Works matching AU Cho, S-G

Mutation in TET2 or TP53 predicts poor survival in patients with myelodysplastic syndrome receiving hypomethylating treatment or stem cell transplantation.

Impact of IKZF1 deletions on long-term outcomes of allo-SCT following imatinib-based chemotherapy in adult Philadelphia chromosome-positive ALL.

Identification of molecular and cytogenetic risk factors for unfavorable core-binding factor-positive adult AML with post-remission treatment outcome analysis including transplantation.

PBSC vs BM grafts with myeloablative conditioning for unrelated donor transplantation in adults with high-risk ALL.

Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?

Survival benefits with transplantation in secondary AML evolving from myelodysplastic syndrome with hypomethylating treatment failure.

Risk and prognostic factors for acute GVHD based on NIH consensus criteria.

Successful treatment with tandem consolidation using <sup>90</sup>yttrium-ibritumomab tiuxetan (Zevalin) and high-dose therapy with autologous PBSCT in a patient with relapsed mantle cell lymphoma presenting as multiple lymphomatous polyposis.

HLA-matched sibling transplantation with BM and CD34<sup>+</sup>-purified PBSCs in adult patients with high-risk severe aplastic anemia to overcome graft rejection without an increase in GVHD.

Azacytidine treatment after discontinuation of immunosuppressants in patients with myelodysplastic syndrome and relapse after allo-SCT at a single center.

Potential role of adoptively transferred allogeneic WT1-specific CD4<sup>+</sup> and CD8<sup>+</sup> T lymphocytes for the sustained remission of refractory AML.

Overcoming various comorbidities by G-CSF-primed unmanipulated BM SCT in adult patients with AML.

Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Anti-leukaemic role of acute GvHD after unrelated haematopoietic stem cell transplantation in intermediate- to high-risk acute myelogenous leukaemia.

Vascular endothelial growth factor (VEGF) is associated with reduced severity of acute graft-versus-host disease and nonrelapse mortality after allogeneic stem cell transplantation.

Transient Plasma Measured by Fixed Electric Probes in the Scrape-Off Layer of Korean Superconducting Tokamak Advance Research (KSTAR).

Conditioning with high-dose cyclophosphamide may not be sufficient to provide a long-term remission of paroxysmal nocturnal hemoglobinuria following syngeneic peripheral blood stem cell transplantation.

Pre-emptive ganciclovir treatment can play a role in restoration of hematopoiesis after allogeneic bone marrow transplantation.

Gallbladder carcinoma and chronic cholescystitis: differentiation with two-phase spiral CT.

Cementless total ankle arthroplasty in diabetic neuropathic arthropathy.

Arginine methylation-dependent regulation of ASK1 signaling by PRMT1.

Effect of Follicle Stimulation Hormone and Luteinizing Hormone on Cumulus Cell Expansion and In Vitro Nuclear Maturation of Canine Oocytes.

The first case of acute lymphoblastic leukemia with the e19a2 BCR-ABL1 transcript: imatinib therapy followed by unrelated donor transplantation induces a durable molecular response.

Donor-specific differences in long-term outcomes of myeloablative transplantation in adults with Philadelphia-negative acute lymphoblastic leukemia.

Reduced-intensity conditioning allogeneic stem cell transplantation is a potential therapeutic approach for adults with high-risk acute lymphoblastic leukemia in remission: results of a prospective phase 2 study.

Feasibility of NIH consensus criteria for chronic graft-versus-host disease.

Tuberculosis before hematopoietic stem cell transplantation in patients with hematologic diseases: report of a single-center experience.

Infectious complications associated with alemtuzumab use for allogeneic hematopoietic stem cell transplantation: comparison with anti-thymocyte globulin.

Transient trisomy 8 abnormality in Philadelphia-negative cells during imatinib mesylate treatment of chronic myelogenous leukemia.